Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation

BACKGROUND: Epithelial-mesenchymal transition (EMT) played an important role in the progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). However, whether sorafenib could be used to suppress the EMT of HCC after insufficient RFA and further prevent the progr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Dong, Shuying, Kong, Jian, Kong, Fandong, Kong, Jinge, Gao, Jun, Ji, Liang, Pan, Bing, Chen, Lian, Zheng, Lemin, Sun, Wenbing
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4663721/
https://ncbi.nlm.nih.gov/pubmed/26620566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1949-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares